Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,408Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8ELI LILLY AND CO

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LASMIDITAN SUCCINATE

US Patent Number : 7423050

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211280

Patent Use Code : U-1719

Delist Requested :

Patent Use Description : ACUTE TREATMENT OF MIG...

Patent Expiration Date : 2028-02-17

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LASMIDITAN SUCCINATE

US Patent Number : 7423050

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211280

Patent Use Code : U-1719

Delist Requested :

Patent Use Description : ACUTE TREATMENT OF MIG...

Patent Expiration Date : 2028-02-17

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LASMIDITAN SUCCINATE

US Patent Number : 11053214

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211280

Patent Use Code : U-1719

Delist Requested :

Patent Use Description : ACUTE TREATMENT OF MIG...

Patent Expiration Date : 2037-12-05

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LASMIDITAN SUCCINATE

US Patent Number : 11053214

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211280

Patent Use Code : U-1719

Delist Requested :

Patent Use Description : ACUTE TREATMENT OF MIG...

Patent Expiration Date : 2037-12-05

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LASMIDITAN SUCCINATE

US Patent Number : 11053214

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211280

Patent Use Code : U-1719

Delist Requested :

Patent Use Description : ACUTE TREATMENT OF MIG...

Patent Expiration Date : 2037-12-05

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LASMIDITAN SUCCINATE

US Patent Number : 7423050

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211280

Patent Use Code : U-1719

Delist Requested :

Patent Use Description : ACUTE TREATMENT OF MIG...

Patent Expiration Date : 2028-02-17

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LASMIDITAN SUCCINATE

US Patent Number : 12071423

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211280

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-07-06

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LASMIDITAN SUCCINATE

US Patent Number : 12071423

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211280

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-07-06

blank